Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

A 3-month time-restricted eating (TRE) protocol resulted in up to one year of sustained weight loss in people with overweight ...

Weight-loss injections could help to reduce the risk of cancer. This finding comes at a time when obesity rates continue to rise globally, with significant implications for public health policies ...

We see significant improvement in MASH in our surgical weight loss patients, and it seems to be directly related to the amount of weight lost. The clinical implications are that this shows another ...